FDA Compliance for Peptide Therapy and BPC 157 Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling